Clinical efficacy on drynaria injection for delayed healing of fracture patients
10.3969/j.issn.1005-1678.2016.11.047
- VernacularTitle:骨碎补注射液对骨折延迟愈合患者的临床疗效
- Author:
Lingchao YE
;
Hongping LIANG
;
Yi DING
- Keywords:
rhizome drynaria;
delayed fracture healing;
NGF;
BMP-2
- From:
Chinese Journal of Biochemical Pharmaceutics
2016;36(11):157-159
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical study on drynaria injection for delayed healing of fracture patients.Methods 108 patients with fracture delayed union from February 2010 to February 2016 in our hospital were selected and randomly divided into the control group and the experiment group by different treatment,54 cases in each group.The control group were treated by conventional therapy,the experiment group were treated with drynaria rhizome injection on the bases of control group.The total effective rate,serum alkaline phosphatase,NGF and BMP-2 levels were observed and compared after treatment.Results After treatment,the total effective rate of experiment group was higher than control group (P<0.05);After treatment for 7 and 14 days,the serum alkaline phosphatase level of the two groups were significantly increased (P<0.05),and compared with the control group, the serum alkaline phosphatase content of the experimental group was higher (P<0.05);After treatment for 7 and 14 days,the serum NGF and BMP-2 levels of two groups were significantly increased(P<0.05),and compared with the control group,the experimental group was higher than those in the control group.Conclusion Injection of rhizoma drynariae in the treatment of delayed healing of patients with significant effect,increase the levels of serum alkaline phosphatase, serum NGF and BMP-2,promote fracture healing in patients and improve clinical efficacy.
